Novel compounds that are modulators of PPAR-type receptors having the structural formula (I):
are formulated into pharmaceutical compositions suited for administration in human or veterinary medicine (in dermatology, and in the field of cardiovascular diseases, immune diseases and/or diseases linked to the metabolism of lipids), or, alternatively, into cosmetic compositions.
具有结构式(I)的调节
PPAR型受体的新化合物被制成适用于人类或兽医药物的制剂(在皮肤科、心血管疾病、免疫疾病和/或与脂质代谢相关的疾病中),或者制成化妆品制剂。